Skip to main content
. 2020 Jan 30;10:1493. doi: 10.1038/s41598-020-58438-0

Figure 12.

Figure 12

EGFR and BIRC5 expression are negatively associated with metastasis-free survival in patients with basal-like tumors. Using an 855-patient breast cancer dataset, patients with basal-like tumors (N = 140) were divided into four groups based on expression levels of EGFR and BIRC5: EGFRhighBIRC5high, EGFRhighBIRC5low, EGFRlowBIRC5high, EGFRlowBIRC5low. Kaplan-Meier curves were generated to assess the effect of high versus low expression of the two genes on (a) liver relapse-free survival, (b) lung relapse-free survival, and (c) metastasis-free survival (MFS) time. Log-rank tests were performed to determine statistical significance (*p < 0.05, **p < 0.01); p-values are listed in Supplementary Table S6.